Your browser doesn't support javascript.
loading
Preclinical Assessment of Paclitaxel- and Trastuzumab-Delivering Magnetic Nanoparticles Fe3O4 for Treatment and Imaging of HER2-Positive Breast Cancer.
Guo, Liting; Zhang, Hongming; Liu, Ping; Mi, Tianai; Ha, Da; Su, Li; Huang, Lei; Shi, Yan; Zhang, Jun.
Afiliación
  • Guo L; Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang H; Department of Respiratory Medicine, Yancheng Third People's Hospital, The Affiliated Yancheng Hospital of Southeast University Medical College, Yancheng, China.
  • Liu P; Department of Oncology, Jiangsu Institute of Cancer Research, Jiangsu Cancer Hospital, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.
  • Mi T; Lianren Digital Health Technology Company, Ltd., Shanghai, China.
  • Ha D; Lianren Digital Health Technology Company, Ltd., Shanghai, China.
  • Su L; Lianren Digital Health Technology Company, Ltd., Shanghai, China.
  • Huang L; Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shi Y; Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang J; Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Front Med (Lausanne) ; 8: 738775, 2021.
Article en En | MEDLINE | ID: mdl-34778301

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza